Nutrigenomics - Global Strategic Business Report

Report
89 Pages
April 2024
Region: Global
Global Industry Analysts, Inc
ID: 5304264

Global Nutrigenomics Market to Reach $2.5 Billion by 2030

The global market for Nutrigenomics estimated at US$715 Million in the year 2022, is projected to reach a revised size of US$2.5 Billion by 2030, growing at a CAGR of 17% over the analysis period 2022-2030. Reagents & Kits, one of the segments analyzed in the report, is projected to record 18.1% CAGR and reach US$1.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Services segment is readjusted to a revised 14.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $209.2 Million, While China is Forecast to Grow at 16% CAGR

The Nutrigenomics market in the U.S. is estimated at US$209.2 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$421.9 Million by the year 2030 trailing a CAGR of 16% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.7% and 13.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.8% CAGR.

Select Competitors (Total 33 Featured) -

BASF SE
Cell-Logic
Cura Integrative Medicine
Geneus Health, LLC
Genova Diagnostics
GX Sciences, Inc.
Koninklijke DSM N.V.
Metagenics, Inc.
Nutrigenomix
NutriProCan
Orig3n
Prenetics Limited
Seven Oaks General Hospital, part of Winnipeg Regional Health Authority
The Gene Box
Unilever
Xcode Life

What's New?

Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Nutrigenomics - Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Nutrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 2: World Historic Review for Nutrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 3: World 16-Year Perspective for Nutrigenomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 5: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 6: World 16-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 9: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 10: World Recent Past, Current & Future Analysis for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 11: World Historic Review for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 12: World 16-Year Perspective for Obesity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 13: World Recent Past, Current & Future Analysis for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 14: World Historic Review for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 15: World 16-Year Perspective for Cancer Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 16: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 17: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 18: World 16-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 19: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 21: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 22: World Nutrigenomics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES

Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
Table 23: USA Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 24: USA Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 25: USA 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
Table 26: USA Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 27: USA Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 28: USA 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030

CANADA

Table 29: Canada Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 30: Canada Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 31: Canada 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
Table 32: Canada Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 33: Canada Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 34: Canada 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030

JAPAN

Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 35: Japan Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 36: Japan Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 37: Japan 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
Table 38: Japan Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 39: Japan Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 40: Japan 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030

CHINA

Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
Table 41: China Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 42: China Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 43: China 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
Table 44: China Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 45: China Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 46: China 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030

EUROPE

Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 47: Europe Recent Past, Current & Future Analysis for Nutrigenomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 48: Europe Historic Review for Nutrigenomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 49: Europe 16-Year Perspective for Nutrigenomics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
Table 50: Europe Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 51: Europe Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 52: Europe 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
Table 53: Europe Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 54: Europe Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 55: Europe 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030

FRANCE

Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
Table 56: France Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 57: France Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 58: France 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
Table 59: France Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 60: France Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 61: France 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030

GERMANY

Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 62: Germany Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 63: Germany Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 64: Germany 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
Table 65: Germany Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 66: Germany Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 67: Germany 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030

ITALY

Table 68: Italy Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 69: Italy Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 70: Italy 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
Table 71: Italy Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 72: Italy Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 73: Italy 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030

UNITED KINGDOM

Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 74: UK Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 75: UK Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 76: UK 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
Table 77: UK Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 78: UK Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 79: UK 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030

REST OF EUROPE

Table 80: Rest of Europe Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 81: Rest of Europe Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 82: Rest of Europe 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
Table 83: Rest of Europe Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 84: Rest of Europe Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 85: Rest of Europe 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030

ASIA-PACIFIC

Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 87: Asia-Pacific Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 88: Asia-Pacific 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
Table 89: Asia-Pacific Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 90: Asia-Pacific Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 91: Asia-Pacific 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030

REST OF WORLD

Table 92: Rest of World Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 93: Rest of World Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 94: Rest of World 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
Table 95: Rest of World Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 96: Rest of World Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 97: Rest of World 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030

IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

BASF SE
Cell-Logic
Cura Integrative Medicine
Geneus Health, LLC
Genova Diagnostics
GX Sciences, Inc.
Koninklijke DSM N.V.
Metagenics, Inc.
Nutrigenomix
NutriProCan
Orig3n
Prenetics Limited
Seven Oaks General Hospital, part of Winnipeg Regional Health Authority
The Gene Box
Unilever
Xcode Life

Table Information

Report Attribute	Details
No. of Pages	89
Published	April 2024
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 715 Million
Forecasted Market Value ( USD ) by 2030	$ 2500 Million
Compound Annual Growth Rate	16.9%
Regions Covered	Global

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5415EUR$5,600USD£4,620GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€10288EUR$10,640USD£8,778GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€16244EUR$16,800USD£13,860GBP

Global Nutrigenomics Market to Reach $2.5 Billion by 2030

The U.S. Market is Estimated at $209.2 Million, While China is Forecast to Grow at 16% CAGR

Select Competitors (Total 33 Featured) -

What's New?

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Global Nutrigenomics Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, and Services), By End User (Hospitals & Clinics, Online Platforms, and Others), By Application, By Regional Outlook and Forecast, 2023 - 2030

Global Nutrigenomics Market by Product (Reagents & Kits, Services), Application (Cancer, Cardiovascular Diseases, Obesity) - Forecast 2024-2030

Nutrigenomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Global Nutrigenomics Market 2024-2028